Anti-IL13 therapy(Generate Biomedicines)

N/A

Report date: 2023/11/09 17:20:18

Base Information

Drug NameAnti-IL13 therapy(Generate Biomedicines)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionAnti-IL13
TargetsInterleukin-13
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenerate Biomedicines Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A